ArticleWorld journal of oncology2025
Differentiating Malignant and Healthy Areas in Isolated Kidney Samples Through Infrared Visualization Techniques.
Article in World journal of oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Because partial nephrectomy (PN) may remove malignant tissue while maintaining kidney function, it is currently the gold standard for nephrectomy. However, the blood arteries that supply the kidney are clamped at the start of the procedure. The most common method for evaluating surgical margins during PN is intraoperative frozen section (FS) evaluation. Its long duration and high false-negative rate question its reliability and efficacy. This encouraged us to search for a much quicker and easier method. Methods: The infrared (IR) imaging approach uses the differences in optical density between tumor and healthy tissue to create the sharp contrast in the IR images. The cancerous kidneys were examined after a radical nephrectomy. Following the removal of the cancerous tissue and some of the surrounding healthy tissue, the samples were examined using the IR method. For the IR analysis, we created specific software. Following that, tissue samples taken from both healthy and malignant areas were subjected to a histomorphological analysis. Results: Experiments showed that malignant tissue appeared as areas of high blackness in the IR picture, while healthy tissue appeared as areas of high illumination. Our software highlighted the areas of the IR image that were associated with the healthy and malignant portions, computed their average brightness, and calculated the ratio of the average illumination (RAI) of the malignant area to that of the healthy area. RAI is an interval of numbers obtained as a result of dividing the average brightness of all dark areas in all examined samples by all light areas of all examined samples. The 95% probability interval for RAIs taking place, which ranged from 0.25 to 0.41, was calculated. The location of the malignancy was then identified by a histomorphological examination. The compliance between histomorphological results and the outcomes of IR examination was confirmed in all cases. Conclusions: The IR imaging technique offers significant promise for improving the accuracy and efficiency of margin assessment during kidney cancer surgeries. The IR imaging technique can provide immediate feedback on the tumor boundaries, which could potentially reduce the duration of warm ischemia during surgery. Subsequent investigations should be focused on verifying the technology in further clinical trials and investigating its integration into the surgical process, which could result in its acceptance as a standard instrument for intraoperative decision-making in kidney cancer operations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.